Bellevue Life Sciences Acquisition Corp. (BLACU) Financial Analysis & Valuation | Quarter Chart
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The c... more
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect ... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $6.98M | Exchange | NASDAQ |
| Sector | Financial Services | Industry | Shell Companies |
| Country | US | CEO | Kuk Hyoun Hwang |
| IPO Date | 2023-02-10 | CAGR | — |
| Employees | — | Website | www.bellevuespac.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 274.78% | Total Yield | 274.78% |
BLACU chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $-921,416 | P/E | — | Forward P/E | — | PEG | — |
| P/S | 5.4 | P/B | 0.01 | P/CF | -0.18 | P/FCF | -1.32 |
| Sales | $1.81M | Sales 1Y | — | Sales 3Y | — | Sales 5Y | — |
| EPS | — | EPS 1Y | — | EPS 3Y | — | EPS 5Y | — |
| Sales QoQ | -34.79% | EPS QoQ | -77.78% | Sales QoQ Avg | -22.95% | EPS QoQ Avg | -374.32% |
| Gross Margin | -98.82% | Operating Margin | -933.75% | Profit Margin | -836.91% | ROCE | -11.19% |
| ROA | -9% | ROE | -16% | Altman Z Score | -0.51 | Piotroski Score | 5 |
| Current Ratio | 0.18 | Quick Ratio | 0.14 | Cash Ratio | 0.1 | Op. CF Ratio | -0.15 |
| Debt/Equity | 0.01 | Debt/Assets | 0 | Lt Debt/Equity | 0 | Lt Debt/Cap. | 0 |
| Intrst Cov. | -34 | Inventory Turnover | 6.05 | Asset Turnover | 0.01 | Receivables Turnover | 5.2 |
| Enterprise Value | $-921,416 | P/E Ratio | — |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 5.4 | P/B Ratio | 0.01 |
| P/CF Ratio | -0.18 | P/FCF Ratio | -1.32 |
| EPS | — | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | — | Gross Margin | -98.82% |
| Operating Margin | -933.75% | Profit Margin | -836.91% |
| ROE | -16% | ROA | -9% |
| ROCE | -11.19% | Current Ratio | 0.18 |
| Quick Ratio | 0.14 | Cash Ratio | 0.1 |
| Debt/Equity | 0.01 | Interest Coverage | -34 |
| Altman Z Score | -0.51 | Piotroski Score | 5 |
View Bellevue Life Sciences Acquisition Corp. financial charts →
Bellevue Life Sciences Acquisition Corp. (BLACU) valuation & financials
Bellevue Life Sciences Acquisition Corp. (BLACU) has a market capitalization of $6.98M. It operates in the Financial Services sector (Shell Companies).
Compare with other Financial Services companies: Berkshire Hathaway (BRK-B) · JPMorgan Chase (JPM) · Visa (V) · Mastercard (MA) · ICBC (1398.HK) · Bank of America (BAC)
Bellevue Life Sciences Acquisition Corp. revenue & earnings charts →